Development and evaluation of oral controlled release chlorpheniramine-ion exchange resinate suspension

Indian Journal of Pharmaceutical Sciences

Volumn 70, Issue 4, 2008, Pages 531-534

  Kadam, A ^a   Sakarkar, D ^a   Kawtikwar, P ^a  

^a SN Institute of Pharmacy   (India)

Author keywords

Chlorpheniramine maleate; Controlled release; Formulation; Indion 244; Ion exchange resin; Suspending agent

Indexed keywords

CHLORPHENIRAMINE MALEATE; EUDRAGIT RS; ION EXCHANGE RESIN;

ARTICLE; COMPLEX FORMATION; CONTROLLED RELEASE FORMULATION; DRUG ADSORPTION; DRUG STABILITY; ION EXCHANGE; MICROCAPSULE; MICROENCAPSULATION; SUSPENSION; THERMOSTABILITY;

EID: 58149096302     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.44613     Document Type: Article

References (8)

1. Raghunathan Y, Amsel L, Hinsvork O, Bryant W. Sustained release drug delivery system: Coated ion exchange resin system for phenylpropanolamine and other drugs. J Pharm Sci 1981;70:379-84.
2. st ed. London: The Pharmaceutical Press; 1989. p. 436.
3. Sayed UV, Amrita N. Oral controlled release bromhexine ion exchange resinate suspension formulation. Indian Drugs 2000;37:185.
4. Irwin WJ. Drug delivery by ion-exchange. Drug Develop Ind Pharm 1987;13:2051.
5. Jaiswal SB, Bedi GS. Studies on sustained release formulation of propranolol hydrochloride with ion exchange resins. Indian Drugs 1980;18:102.
6. Sanghavi NM, Kamath DS, Amin DS. Ion exchange resins as matrices for controlled drug release. Indian Drugs 1988;26:28.
7. Omar LS, James CP. Evaluation of sustained release aqueous suspension containing microencapsulated drug resin complex. Drug Develop Ind Pharm 1989;15:1275-87.
8. Bhalerao SS, Rane MS. Studies on sustained release liquid oral formulation of diltiazem hydrochloride, reconstitutable suspension. Indian Drugs 2003;40:701-6.